Closed
The Marked Chart Wire · Health
Abbott
Abbott's TECTONIC trial reported that its SonicForce coronary IVL system achieved a 97 percent procedural success rate and a 0.3 percent 30-day target lesion failure rate among 335 patients.
Prices from Before the open · based on Fri close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
Johnson & Johnson
Johnson & Johnson says its Impella heart pumps are linked to lower mortality rates in patients. The company released the clinical data on Friday.
FDA
The US Food and Drug Administration has approved revised labeling for three estradiol patch products.
Velo
The Food and Drug Administration granted marketing approval to 24 Velo nicotine pouch items, marking a significant regulatory achievement for British American Tobacco.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.